R&D

By James Leahy, University of South Florida

Today is World Cancer Day which means we internationally encourage raising awareness about cancer while promoting and supporting efforts in prevention, early detection and advancement in treatments.

The cancer drug business is quite a profitable one. A “high risk, high reward” proposition has been the narrative for those in research and development (R&D). Successes, marketing, patent protection and discovery cost money.

On November 8, I published an article titled, "Whoever Wins On Election Day 2016, American Science Is Still #1 In The World." Tha